NASDAQ
Allogene Therapeutics, Inc. (ALLO) has a interest coverage ratio of -192.50x as of Friday, May 29, 2026. This represents a 48.99% increase compared to its 12-month average of -377.35x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.